Hepatitis B surface antigen (HBsAg) is a marker of one of the causative agents of post-transfusion (serum) hepatitis (Giles et al, 1969 ) and as such must be identified in donor blood before transfusion. Over the past few years, a number of techniques have been applied to the detection of HBsAg, ranging in sensitivity and sophistication from agar-gel diffusion (AGD, first generation test) to radioimmunoassay (RIA, third generation test). The experience of many laboratories clearly indicates that third generation methodology must be adopted if maximum efficiency of blood donor testing is to be achieved (Ling and Overby, 1972; Cayzer et al, 1974; Hopkins et al, 1975) . Unfortunately, third generation reagents are available to the majority of blood transfusion centres only on a commercial basis, the cost ranging from 10 pence per test (Hepatest-Reverse Passive Haemagglutination (RPHA) Wellcome Reagents) to 50 pence per test or more, apparently depending on geographical location (AUSRIA-IT, Radioimmunoassay (RIA), Abbott Laboratories).
In 1973 details were published of a tanned-cell haemagglutination inhibition (HAI) technique, utilizing Terasaki tissue culture trays, which achieved a sensitivity similar to RIA but at a fraction of the cost (Hopkins and Das, 1973) . This technique has recently been evaluated by three Scottish regional transfusion centres testing over 70 000 blood donations together with various well documented HBsAg panels (Hopkins et al, 1975 One unit (approximately 450 ml) of human group O rhesus negative blood collected in anticoagulant (citrate phosphate dextrose), and not more than three weeks old, was obtained from the blood bank. It was first necessary to determine the molarity of phosphate buffer pH 7-2 required for the selection process. Isotonic (0-2 M) phosphate buffer containing 0-1 % sodium azide was serially diluted in deionized water, and 0-1 ml of fresh, well mixed blood was added to 2 ml of each dilution of phosphate buffer in a test tube, mixed thoroughly, and allowed to stand for 60 minutes. That solution showing at least 50% haemolysis was arbitrarily taken as optimum. The molarity at this point was usually 0-045 M to 0-030 M. The remainder of the unit of blood was then mixed with phosphate buffer (adjusted to optimum molarity) in the ratio 1 volume of cells to 4 volumes of buffer, and the bulk volume was split into 200 ml aliquots for ease of subsequent washing. After 60 minutes at room temperature the aliquots were spun at 1000 rev/min for 15 minutes at 20°C or room temperature using an MSE 6L centrifuge, the supernatant was removed, and fresh hypotonic buffer was added. This procedure was repeated until only a minimum of haemolysis was observed in the supernatant, and the remaining cellsaccountedforapproximately 50% of those originally present. Wet film microscopy showed that the cells had lost their conventional biconcave morphology and become rounded. They were subsequently referred to as 'spherocytes'.
FIXATION OF SPHEROCYTES
In a pilot experiment some spherocytes were divided into aliquots to which glutaraldehyde (Koch Lights, 250,) was added to give the following concentrations: 1 in 100, 1 in 200, 1 in 400, 1 in 800, 1 in 1600, 1 in 3200, and 1 in 6400. After thorough mixing, the cell aliquots containing fixative were left at room temperature overnight. The following morning cells from each aliquot were examined microscopically and subjected to a 'water-resistance' test, which 364 involved adding 25 ,ul of 'settled' spherocytes to 2 ml of deionized water, when properly fixed cells resisted haemolysis. Dilutions of glutaraldehyde up to 1 in 1600 (0106%) produced acceptable fixation, although dilutions up to 1 in 400 (0-25%) tended to distort the shape of the spherocytes, causing them to revert to biconcave discs. The remaining spherocytes (from the unit pack) were fixed in the appropriate concentration of glutaraldehyde (approximately 0 06%) as above and stored at 4°C in phosphate buffer containing 0-1% sodium azide. All solutions contained 0-1% sodium azide.
TANNING, SENSITIZATION, AND STABILIZATION OF FIXED SPHEROCYTES (for one million HAI tests) Sixteen ml of packed glutaraldehyde-fixed spherocytes were washed twice with 500 ml volumes of physiological saline (MRC bottle spun at 1000 rev/min for 5 minutes in an MSE 6L centrifuge at room temperature). The deposited cells were resuspended in 500 ml of tannic acid (M & B at a 1 in 60 000 dilution in phosphate buffer 0 15 M pH 7-2 containing 0 1% sodium azide and previously heated to 37°C) and left in a 37°C waterbath for 15 minutes with occasional mixing. The tanned cells were spun down as before, washed twice with 500 ml of phosphate buffered saline (PBS) pH 6-4 containing 0I1% sodium azide, and finally resuspended in 400 ml PBS pH 6 4.
Twenty millilitres HBsAg, prepared as previously described (Hopkins and Das, 1973) and containing both 'd' and 'y' antigenic determinants, was added, and the spherocyte-antigen suspension was mixed continuously at room temperature (see addendum). After 20 hours a 1 ml aliquot was removed, stabilized as previously described (Hopkins and Das, 1973) , and used to titrate a known standard HBsAb containing serum. Sampling was repeated at approximately 20-hour intervals until a satisfactory sensitivity was achieved. The bulk reagent was removed from the mixer and the cells were recovered by centrifugation as before. The sensitized cells were then stablilized by resuspension and mixing for 4 hours at room temperature in 500 ml PBS pH 7-2 containing 2% normal human serum to give a cell suspension of approximately 3-2% (or 10 times working concentrations).
Storage of these cells overnight at 4°C was followed by a repetition of the stabilizing procedure. Thereafter, the 3-2% suspension of cells was dispersed into 50 ml aliquots and stored at 4°C ready for pasteurization.
PASTEURIZATION AND STORAGE OF HBsAg COATED SPHEROCYTES
Immediately before pasteurization the coated spherocytes were pelleted and resuspended to the same volume with PBS pH 7-2 containing 0105% phenol. They were then left for 12-16 hours in a 60°C waterbath, allowed to cool, divided into smaller aliquots (for convenience), and stored at 4°C until required when each aliquot would be diluted 10-fold with PBS pH 7-2 to achieve working strength.
The coated cells could also be stored at -20°C or in the lyophilized state without appreciable loss of sensitivity. Comment Recent reports have highlighted the inadequacies of first and second generation methods of HBsAg testing (Ling and Overby, 1972; Cayzer et al, 1974; Hopkins et al, 1975) . The American Red Cross appear to have opted for RIA as a means of blood donor screening, while transfusion centres in the United Kingdom seem to favour haemagglutination.
It is the purpose of this communication to emphasize that third generation testing efficiency is available at a fraction of the cost of purchasing commercial reagents. Preparation of sufficient HAI reagents for approximately one million tests is described in detail using a process which is readily reproducible (we have recently prepared a second batch of reagents sufficient for 3 5 million HAI tests) and requires relatively unsophisticated laboratory equipment. The cost of one million RPHA tests is £80 000, while a similar number of RIA tests bought commercially could cost £500 000.
Experience has shown that HAI reagents are extremely stable in that they will survive 4°C for over one year, repeated freezing and thawing, lyophilization and exposure to 2-5 mega rads of gamma irradiation from a cobalt source (Courtesy of Ethicon Ltd, Edinburgh), neither does transport over thousands of miles via air freight appear to have an adverse effect, even when cells are maintained in the liquid state.
The safety of laboratory staff handling hepatitis B testing reagents is of paramount importance. Until it is possible to evaluate the biological activity of HBAg it is essential that every reasonable precaution should be taken to ensure the safety of such reagents. For this reason we have attempted to incorporate into reagent preparation accepted methods of virus inactivation, combining the principles of chemical and physical inactivation, namely, (a) betapropiolactone treatment and ultraviolet irradiation of raw serum (LoGrippo et al, 1971) 
